// App-Quantinova.ai

AB0513 (2022) : COVID-19 PREVENTION IN PATIENTS WITH MODERATE-TO-SEVERE LUPUS DURING THE PANDEMIC: RESULTS FROM THE BILAG-BIOLOGICS REGISTER (BILAG-BR)

Researchers

Presenter

  • S. Dyball

Principal Investigators

  • M. Rodziewicz

  • E. Sutton

  • B. Parker

  • I. N. Bruce

Medical Centers

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, M13 9PT, United Kingdom

  • NIHR Manchester Biomedical Research Unit, Centre for Musculoskeletal Research, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • UCB and Eli Lilly and Company

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved